Macquarie Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-7,801
| Closed | -$902K | – | 1706 |
|
|
2023
Q3 | $902K | Buy |
7,801
+1,744
| +29% | +$202K | ﹤0.01% | 1363 |
|
|
2023
Q2 | $623K | Sell |
6,057
-2,772
| -31% | -$285K | ﹤0.01% | 1428 |
|
|
2023
Q1 | $964K | Sell |
8,829
-79,685
| -90% | -$8.7M | ﹤0.01% | 1364 |
|
|
2022
Q4 | $10.1M | Sell |
88,514
-1,719,050
| -95% | -$196M | 0.01% | 834 |
|
|
2022
Q3 | $112M | Sell |
1,807,564
-45,054
| -2% | -$2.79M | 0.14% | 191 |
|
|
2022
Q2 | $148M | Sell |
1,852,618
-84,649
| -4% | -$6.75M | 0.17% | 144 |
|
|
2022
Q1 | $204K | Buy |
1,937,267
+178,354
| +10% | +$18.8K | 0.16% | 128 |
|
|
2021
Q4 | $190M | Buy |
1,758,913
+132,842
| +8% | +$14.3M | 0.16% | 162 |
|
|
2021
Q3 | $178M | Buy |
1,626,071
+55,058
| +4% | +$6.03M | 0.15% | 161 |
|
|
2021
Q2 | $147M | Buy |
1,571,013
+1,561,546
| +16,495% | +$146M | 0.12% | 205 |
|
|
2021
Q1 | $872K | Hold |
9,467
| – | – | ﹤0.01% | 1426 |
|
|
2020
Q4 | $693K | Buy |
9,467
+1,210
| +15% | +$88.6K | ﹤0.01% | 1393 |
|
|
2020
Q3 | $641K | Hold |
8,257
| – | – | ﹤0.01% | 1345 |
|
|
2020
Q2 | $459K | Sell |
8,257
-1,043
| -11% | -$58K | ﹤0.01% | 1366 |
|
|
2020
Q1 | $275K | Hold |
9,300
| – | – | ﹤0.01% | 1385 |
|
|
2019
Q4 | $337K | Buy |
+9,300
| New | +$337K | ﹤0.01% | 1481 |
|
|
2019
Q2 | – | Sell |
-96,636
| Closed | -$2.55M | – | 1907 |
|
|
2019
Q1 | $2.55M | Buy |
96,636
+96,536
| +96,536% | +$2.55M | ﹤0.01% | 927 |
|
|
2018
Q4 | $2K | Sell |
100
-1,600
| -94% | -$32K | ﹤0.01% | 2222 |
|
|
2018
Q3 | $33K | Sell |
1,700
-17,300
| -91% | -$336K | ﹤0.01% | 1802 |
|
|
2018
Q2 | $315K | Sell |
19,000
-10,200
| -35% | -$169K | ﹤0.01% | 1510 |
|
|
2018
Q1 | $415K | Buy |
29,200
+16,300
| +126% | +$232K | ﹤0.01% | 1451 |
|
|
2017
Q4 | $188K | Buy |
12,900
+8,700
| +207% | +$127K | ﹤0.01% | 1747 |
|
|
2017
Q3 | $53K | Buy |
+4,200
| New | +$53K | ﹤0.01% | 2000 |
|